Genetic Signatures Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was AUD 16.94 million compared to AUD 35.42 million a year ago. Net loss was AUD 14.05 million compared to net income of AUD 3.06 million a year ago.

Basic loss per share from continuing operations was AUD 0.098 compared to basic earnings per share from continuing operations of AUD 0.0214 a year ago. Diluted loss per share from continuing operations was AUD 0.098 compared to diluted earnings per share from continuing operations of AUD 0.0211 a year ago.